Abstract
Lung carcinoma is the main cause of cancer-related morbidity and mortality in the world, with more than 2.2 million of new cases and 1.8 of deaths estimated to 2020. The most common type of lung cancer is the non-small cell lung carcinoma (NSCLC). The treatment strategy in advanced NSCLC has evolved from empirical chemotherapy to a personalized approach based on better histological and mo…